Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Galmed Pharmaceuticals (GLMD) Q3 2026 Earnings
GLMD
8
Jul
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q3 2026
-3.04
-2.14
-1.23
-0.33
Details
Expected EPS
-3.04
Actual EPS
N/A
Surprise EPS
3.04
Surprise Percent
+100%
Description
Galmed Pharmaceuticals (GLMD) will report earnings of for Q3 2026 on July 08, 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login